| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 21/10/2014 | 14:00 | PR Newswire (US) | Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTO | AMEX:LRP | Lorus Therapeutics, (New) |
| 03/10/2014 | 13:00 | PR Newswire (US) | Aptose Biosciences to Present at the 2014 BIO Investor Forum | AMEX:LRP | Lorus Therapeutics, (New) |
| 01/10/2014 | 23:16 | PR Newswire (Canada) | Aptose Biosciences Announces Reverse Stock Split | AMEX:LRP | Lorus Therapeutics, (New) |
| 29/09/2014 | 14:30 | PR Newswire (US) | Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & S... | AMEX:LRP | Lorus Therapeutics, (New) |
| 25/09/2014 | 15:48 | PR Newswire (US) | Aptose Biosciences to Present at Upcoming Investor Conferences | AMEX:LRP | Lorus Therapeutics, (New) |
| 08/09/2014 | 13:00 | PR Newswire (US) | Aptose Biosciences Recruits Stephen B. Howell, M.D. to Act in the Capacity of Chief Medical Officer | AMEX:LRP | Lorus Therapeutics, (New) |
| 02/09/2014 | 13:00 | PR Newswire (US) | Lorus Therapeutics Implements Name Change to Aptose Biosciences | AMEX:LRP | Lorus Therapeutics, (New) |
| 19/08/2014 | 22:00 | PR Newswire (US) | Lorus Therapeutics Announces Results of Annual and Special Meeting of Shareholders | AMEX:LRP | Lorus Therapeutics, (New) |
| 07/08/2014 | 13:00 | PR Newswire (US) | Lorus Therapeutics to Present at the Canaccord Genuity 34th Annual Growth Conference | AMEX:LRP | Lorus Therapeutics, (New) |
| 28/07/2014 | 13:00 | PR Newswire (US) | Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blo... | AMEX:LRP | Lorus Therapeutics, (New) |
| 15/07/2014 | 22:46 | PR Newswire (US) | Lorus Therapeutics Reports Results for the Fourth Quarter and Full Year Ended May 31, 2014 | AMEX:LRP | Lorus Therapeutics, (New) |
| 15/07/2014 | 22:28 | PR Newswire (US) | Lorus Therapeutics Proposes Name Change to "APTOSE BIOSCIENCES" and Share Consolidation for Potential NASDAQ Listing | AMEX:LRP | Lorus Therapeutics, (New) |
| 10/07/2014 | 13:00 | PR Newswire (US) | Lorus Therapeutics To Host Fourth Quarter and Year End 2014 Financial Results Conference Call and Webcast | AMEX:LRP | Lorus Therapeutics, (New) |
| 19/06/2014 | 13:00 | PR Newswire (US) | Lorus Therapeutics to Present at the 9th JMP Securities Healthcare Conference | AMEX:LRP | Lorus Therapeutics, (New) |
| 16/06/2014 | 13:00 | PR Newswire (Canada) | Lorus Therapeutics to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference | AMEX:LRP | Lorus Therapeutics, (New) |
| 10/06/2014 | 13:30 | PR Newswire (Canada) | Lorus Therapeutics Provides Update on Warrants | AMEX:LRP | Lorus Therapeutics, (New) |
| 23/10/2008 | 22:09 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | AMEX:LRP | Lorus Therapeutics, (New) |
| 21/10/2008 | 14:53 | Edgar (US Regulatory) | -National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25) | AMEX:LRP | Lorus Therapeutics, (New) |
| 17/10/2008 | 14:43 | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | AMEX:LRP | Lorus Therapeutics, (New) |
| 15/10/2008 | 14:00 | Marketwired | Lorus Therapeutics Announces Receipt of Milestone Payment and Extension of Exclusive License Agreement for Virulizin(R) | AMEX:LRP | Lorus Therapeutics, (New) |
| 10/10/2008 | 23:02 | Marketwired | Lorus Therapeutics Announces Voluntary Delisting From the NYSE Alternext | AMEX:LRP | Lorus Therapeutics, (New) |
| 09/10/2008 | 14:15 | Marketwired | Lorus Therapeutics Reports First Quarter Results for Fiscal Year 2009 | AMEX:LRP | Lorus Therapeutics, (New) |
| 03/10/2008 | 18:21 | Edgar (US Regulatory) | Lorus Therapeutics Inc - Report of Foreign Issuer (6-K) | AMEX:LRP | Lorus Therapeutics, (New) |
| 09/09/2008 | 14:15 | Marketwired | Lorus Therapeutics Announces Publication on Drug Levels and Clearance Rates for Anticancer Drug LOR-2040 | AMEX:LRP | Lorus Therapeutics, (New) |
| 20/08/2008 | 14:00 | Marketwired | Lorus Therapeutics Announces the Identification of a Potential Novel Biomarker in Patient Samples From a Clinical Trial of LOR-2 | AMEX:LRP | Lorus Therapeutics, (New) |
| 15/08/2008 | 14:27 | Edgar (US Regulatory) | Lorus Therapeutics Inc - Amended Statement of Beneficial Ownership (SC 13D/A) | AMEX:LRP | Lorus Therapeutics, (New) |
| 08/08/2008 | 23:16 | Marketwired | Lorus Therapeutics Successfully Completes Rights Offering, Raising $3.71 Million | AMEX:LRP | Lorus Therapeutics, (New) |
| 05/08/2008 | 14:00 | Marketwired | Lorus Toxicology Program Supports Novel Route of Administration of the Anticancer Drug LOR-2040 in Bladder Cancer | AMEX:LRP | Lorus Therapeutics, (New) |
| 29/07/2008 | 14:00 | Marketwired | Lorus Therapeutics Announces Allowance of New United States Patent for its Anticancer Drug LOR-2040 | AMEX:LRP | Lorus Therapeutics, (New) |
| 21/07/2008 | 21:24 | PR Newswire (US) | /C O R R E C T I O N from Source -- Lorus Therapeutics Inc./ | NYSE:LRP | |